Jan 14, 2021 · ARA-290 (a.ka. Cibinetide) is a synthetic peptide developed by Araim Pharmaceuticals that consists of 11 amino acids and is entirely derived from the helix beta domain of erythropoietin (EPO). And in case you don’t know the role of EPO in your body:

Nov 5, 2024 · ARA 290 peptide is ideal for people diagnosed with chronic conditions like diabetes, who often suffer from neuropathic pain due to diabetic neuropathy at some point in their lives.

Jul 1, 2020 · “ARA290 protects against early renal allograft injury in rats by reducing macrophage infiltration, improving renal morphology, inhibiting mRNA expression of inflammatory mediators, and weakening the binding affinity of NF-kB to DNA.”

Nov 27, 2024 · ARA 290, also known as cibinetide, is an 11–amino acid peptide that has potent tissue-protective and tissue-regenerative properties. It is called “nonhematopoietic peptide” because ARA 290 exerts its beneficial effects without …

ARA 290, a nonhematopoietic peptide designed from the structure of erythropoietin, interacts selectively with the innate repair receptor that mediates tissue protection. ARA 290 has shown efficacy in preclinical and clinical studies of metabolic control and neuropathy.

ARA 290 is a non-erythropoietic peptide engineered from erythropoietin (EPO), a hormone that stimulates the production of red blood cells. It is a modified version of the naturally occurring hormone, which has been found to have a neuroprotective effect.

ARA-290 is a fascinating peptide derived from Erythropoietin, the hormone responsible for the production of red blood cells. Unlike its parent molecule, ARA-290 does not increase RBC production. Instead, it has incredible pain-inhibiting and neuroprotective effects that can be beneficial to athletes.

Dec 22, 2024 · ARA-290 is a small peptide derived from the helix beta domain of erythropoiefin (EPO). EPO has long been known to exhibit actions beyond the stimulation of red blood cell production in bone marrow.

Cibinetide (ARA290) enhances the proliferation, migration, and resistance to H 2 O 2-induced apoptosis of endothelial colony-forming cells (ECFCs). Cibinetide (ARA290) is an EPO-analog peptide without hematopoietic side-effects but may have neurotrophic and antidepressant effects.

Mar 13, 2015 · ARA 290, a nonhematopoietic peptide designed from the structure of erythropoietin, interacts selectively with the innate repair receptor that mediates tissue protection. ARA 290 has shown efficacy in preclinical and clinical studies of …